SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Pfizer Inc. and Ranbaxy Laboratories Deal Would Delay Generic Lipitor

June 18, 2008 | 
1 min read
NEW YORK (Reuters) - Pfizer Inc. said on Wednesday that Ranbaxy Laboratories Ltd can begin selling a U.S. generic form of its Lipitor cholesterol fighter by late 2011 under a settlement deal, some five months later than Wall Street expectations.
Mergers & acquisitions
Pfizer
MORE ON THIS TOPIC
Perspective view of supermarket aisle. Supermarket with colorful shelves of merchandise and front door and supermarket food cart. Cartoon vector illustration
Immunology and inflammation
Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStar
October 23, 2026
 · 
1 min read
 · 
Annalee Armstrong
3d sketch poster trend collage image of hands hold chess figurine knight queen rival china america trade war economic problem.
China
US explores China biotech restrictions, exempts licensing deals
October 23, 2026
 · 
3 min read
Salary negotiation, pay raise discussion or wages and benefit agreement, business deal or merger and acquisition concept, business people handshake on pile of money banknote after finish agreement.
Deals
Roche bets up to $813M on Zymeworks’ lung cancer trispecific T cell engager
October 23, 2026
 · 
2 min read
 · 
Tristan Manalac
People standing in line. Isolated crowd, queue group back stand. Person wait shopping, airport registration or ticket utter vector concept. People line queue, crowd stay in row illustration
IPO
Biotech notches 31 IPOs already this year, with 4 more joining queue
October 22, 2026
 · 
1 min read
 · 
Gabrielle Masson